Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular biologic staging of lung cancer.

The Annals of thoracic surgery - 1 Feb 2008

D'Amico Thomas A

Abstract excerpt

Clinical and pathologic staging of lung cancer is suboptimal in achieving the goals of assessing prognosis and selecting therapy. Although the technologic developments that allow the generalized use of proteomic and genomic analyses are relatively recent, major progress in understanding the molecular basis of lung cancer has been made. Predicting survival is only the first step in the use of genomics and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, erbB-1

Share to Genes, erbB-2

Share to Neoplasm Staging

Share to Risk Assessment

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 18222207
DOI: 10.1016/j.athoracsur.2007.11.047

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Molecular biologic staging of lung cancer.PMID 18222207Read ↗

Molecular prognostication of non-small cell lung cancer.Semantic proximity Read ↗

Molecular staging and pharmacogenomics. Clinical implications: from lab to patients and back.Semantic proximity Read ↗

Validation of molecular and immunological factors with predictive importance in lung cancer.Semantic proximity Read ↗

Integration of molecular profiling into the lung cancer clinic.Semantic proximity Read ↗

Molecular biology of lung cancer: clinical implications.Semantic proximity Read ↗

Prognostic markers in lung cancer: is it ready for prime time?Semantic proximity Read ↗

A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markersSemantic proximity Read ↗

Biological considerations in lung cancer.Semantic proximity Read ↗

Molecular approaches to lung cancer evaluation.Semantic proximity Read ↗

Biologic and molecular prognostic factors--impact on treatment of patients with non-small cell lung cancer.Semantic proximity Read ↗

Using Protein Microarray as a Diagnostic Assay for Non–Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.